Future iterations may be weekly oral tablets instead of daily dosing
For many patients, the better value is a transparent, provider-led program with ongoing guidance
Interest stems mainly from their metabolic and weight-management effects, but robust human clinical trial evidence supporting direct thyroid or autoimmune benefits is lacking
Over the past two decades, more versions of the medication have hit the market, becoming more accessible to patients and used for a wider range of health concerns, including weight management
Yet by 2000, a strategy had emerged to prolong the effect of GLP-1 signaling: generate DPP-4 resistant peptides that bind and activate (i.e., agonize) GLP-1R
Using non-standard weight-loss drugs that promise quick results can have severe negative effects on the body, even leading to fatal consequences